Related references
Note: Only part of the references are listed.
Review
Biochemistry & Molecular Biology
Yuanyuan An et al.
Summary: Metabolic reprogramming is a key characteristic of malignant tumors. The modification of m6A RNA methylation plays a crucial role in the regulation of tumor cell metabolism.
Article
Multidisciplinary Sciences
Hui Yang et al.
Summary: In this study, a hypoxia-induced lncRNA, CBSLR, was discovered to protect gastric cancer cells from ferroptosis, leading to chemoresistance. The mechanism involves the formation of CBSLR/YTHDF2/CBS signaling axis that destabilizes CBS mRNA and promotes ACSL4 degradation, resulting in decreased ferroptosis.
JOURNAL OF ADVANCED RESEARCH
(2022)
Article
Biochemistry & Molecular Biology
Zhiying Zhao et al.
Summary: The RNA binding motif protein 15 (RBM15) has been found to be mutated or abnormally up-regulated in various cancers, and its high expression is associated with poor prognosis. In pancreatic adenocarcinoma (PAAD), RBM15 overexpression is correlated with patients' overall survival, disease-free interval, progression-free interval, and disease-specific survival. RBM15 expression is also positively correlated with immune infiltrating cells and immune checkpoint markers in certain cancer types. Knockdown of RBM15 inhibits the proliferation of pancreatic cancer cells. Pan-cancer analysis suggests that RBM15 may serve as a prognostic biomarker and immunotherapeutic target for PAAD.
FRONTIERS IN MOLECULAR BIOSCIENCES
(2022)
Article
Oncology
Zegui Ni et al.
Summary: This study reveals that activated JNK signaling is associated with increased expression of METTL3 in bladder cancer. JNK signaling regulates METTL3 expression and global RNA m(6)A levels. Additionally, m(6)A modification is enriched in the 3'-UTR of PD-L1 mRNA, and it is recognized by the m(6)A reader protein IGF2BP1 to mediate the stability and expression levels of PD-L1.
Article
Oncology
Xia Li et al.
Summary: Habitual areca nut chewing is associated with the high prevalence of oral squamous cell carcinoma (OSCC) in South Asia. This study reveals that chronic arecoline exposure induces upregulation of PD-L1, which confers superior cell proliferation, migration, and resistance to T-cell killing to OSCC cells. Targeting PD-L1 might be a potential therapeutic strategy for treating PD-L1-positive OSCC patients, especially those with habitual areca nut chewing.
Article
Cell Biology
Lirong Peng et al.
Summary: Recent studies suggest that lipopolysaccharide (LPS) of intestinal bacteria plays a critical role in immune escape of hepatocellular carcinoma (HCC) through METTL14/MIR155HG/PD-L1 axis regulation. This study provides new insight into understanding the complex immune microenvironment of HCC.
CELL BIOLOGY AND TOXICOLOGY
(2022)
Article
Oncology
Yihao Liu et al.
Summary: This study found that LncRNA-PACERR functions as a key regulator of TAMs in the PDAC microenvironment and revealed novel mechanisms in the cytoplasm and the nucleus.
JOURNAL OF HEMATOLOGY & ONCOLOGY
(2022)
Article
Pathology
Minsun Jung et al.
Summary: Accurate diagnosis and grading of prostate needle biopsies are crucial for prostate cancer management. An AI system called DeepDx has been developed to assist pathologists in making unbiased decisions and improve efficiency. This study validated the performance of DeepDx in prostate cancer diagnosis and grading, and demonstrated its potential value in routine practice by enhancing the general pathologist's diagnostic performance.
Article
Biochemistry & Molecular Biology
Shufang Jin et al.
Summary: This study demonstrates that m6A status is downregulated and two demethylases are upregulated in HNSCC. Silencing the m6A demethylase ALKBH5 suppresses tumor progression. ALKBH5 downregulates the m6A modification of DDX58 mRNA, while HNRNPC binds to the m6A sites of DDX58 mRNA to promote its maturation.
Article
Biochemistry & Molecular Biology
Changwei Lin et al.
Summary: The research demonstrates that m(6)A modification enhances the binding ability of circALG1 to miR-342-5p, promoting its ceRNA function in colorectal cancer (CRC). CircALG1 could be a potential therapeutic target and prognostic marker for CRC.
Article
Biochemistry & Molecular Biology
Yuanlei Chen et al.
Summary: This study identifies TRAF1 as a key player in sunitinib resistance, promoting resistance through modulation of apoptotic and angiogenic pathways. Targeting TRAF1 and its pathways may provide a novel approach for treating sunitinib-resistant patients.
Article
Biochemistry & Molecular Biology
Mathieu N. Flamand et al.
Summary: A study reveals that the m(6)A modification is a novel regulator of mRNA localization in neurons. Loss of m(6)A leads to altered subcellular localization of hundreds of transcripts in hippocampal neurons, and mutation of specific m(6)A sites reduces the localization of neuronal transcripts to neurites. Further experiments confirm these findings.
NUCLEIC ACIDS RESEARCH
(2022)
Article
Biochemistry & Molecular Biology
Zhen Tan et al.
Summary: This study reveals that downregulation of FTO leads to increased m(6)A modifications in the 3'UTR of PDGFC, and then modulates its transcriptional level in an m(6)A-YTHDF2-dependent manner. PDGFC upregulation promotes cell growth, highlighting a potential therapeutic target for PDAC treatment and prognostic prediction.
Article
Multidisciplinary Sciences
Peter Tsvetkov et al.
Summary: Copper is an essential cofactor for all organisms, but excessive copper can lead to cell death. We found that copper-dependent cell death mechanism is different from known mechanisms, and it is related to mitochondrial respiration. Copper directly binds to lipoylated components of the tricarboxylic acid cycle, causing protein aggregation and loss of iron-sulfur cluster proteins, ultimately leading to cell death.
Article
Cell Biology
Jian Feng et al.
Summary: This study reveals the important role of N-6-methyladenosine (m(6)A) in regulating innate immunity against bacterial and viral infections. By examining cellular m(6)A epitranscriptomes, the study shows that many innate immune response genes undergo m(6)A modifications. The findings provide valuable resources for the scientific community.
CELL DEATH & DISEASE
(2022)
Article
Cell Biology
Yue Zhu et al.
Summary: This study revealed that the expression of six transmembrane epithelial antigen of the prostate 2 (STEAP2) is downregulated in papillary thyroid cancer (PTC) tissues. Low STEAP2 expression is associated with aggressive clinicopathological characteristics and poor prognosis in PTC patients. The METTL3-mediated STEAP2 N6-methyladenosine (m6A) modification plays a critical tumor-suppressive role in PTC progression. The METTL3-STEAP2 axis may serve as a potential therapeutic molecular target against PTC.
CELL DEATH & DISEASE
(2022)
Article
Dentistry, Oral Surgery & Medicine
Peng Deng et al.
Summary: Aging of craniofacial skeleton affects the repair and regeneration of bony defects and dental treatment outcomes. Age-related alveolar bone loss may be due to decreased progenitor pool, imbalance in bone metabolism, and bone-fat ratio. The histone demethylase KDM4B plays an essential role in regulating the osteogenesis of oral bone mesenchymal stem cells (OMSCs) and oral bone aging.
INTERNATIONAL JOURNAL OF ORAL SCIENCE
(2022)
Article
Cell Biology
Amalie Grenov et al.
Summary: This study reveals a post-transcriptional mechanism that directs B cell fate commitment by suppressing the plasmablast genetic program and promoting germinal center (GC) B cell fate.
Article
Oncology
A. Markou et al.
Summary: This study evaluated the prognostic value of DNA methylation of selected tumor suppressor genes in circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in early stage non-small cell lung cancer (NSCLC). The results showed that the methylation of these genes was significantly lower in CTCs and ctDNA compared to primary tumors. The combination of DNA methylation analysis in CTCs and ctDNA was associated with worse prognosis in NSCLC patients.
CLINICAL EPIGENETICS
(2022)
Article
Biology
Enjie Li et al.
Summary: This study reveals the involvement of METTL3 in the regulation of homologous recombination repair (HR) and chemotherapeutic response in breast cancer cells. It also demonstrates the role of METTL3 in the m6A modification of the EGF/RAD51 axis, which affects HR activity and DNA damage.
Review
Pharmacology & Pharmacy
Dario P. Anobile et al.
Summary: Malignant mesothelioma is an aggressive rare cancer associated with asbestos exposure and currently incurable due to drug resistance. The alterations in miRNA and splicing machinery may contribute to chemoresistance. The Notch signaling pathway, frequently deregulated in MMe, is involved in cancer stem cell formation and self-renewal, leading to drug resistance and relapses.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY
(2022)
Article
Immunology
Wenyi Zhang et al.
Summary: This study demonstrates the important roles of m6A modification patterns in cervical cancer. Analysis of m6A modification patterns can enhance our understanding of the tumor microenvironment in cervical cancer and facilitate the development of better immunotherapy strategies.
FRONTIERS IN IMMUNOLOGY
(2022)
Review
Immunology
Shuo Yang et al.
Summary: Lung cancer is a common malignancy and non-small cell lung cancer (NSCLC) is the most common type. Epigenetic alterations such as DNA methylation, histone modifications, and noncoding RNA expression are suggested to drive NSCLC development. Inflammation-related tumorigenesis plays a vital role in cancer research, but the exact relationship between immune components and epigenetic changes in inflammation is not clear. The connection between epigenetic drivers, inflammation, and NSCLC needs further investigation.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Immunology
Qi Chen et al.
Summary: This study comprehensively analyzed the epigenetic regulation in rheumatoid arthritis (RA) using differential analysis and cross-analysis. The results identified differentially methylated sites, differentially expressed genes, and differentially expressed miRNAs associated with RA. A comprehensive epigenetic regulatory network was constructed, and core regulatory genes were identified. This study provides a new direction for future research on the epigenetic mechanisms of RA.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Immunology
Wu Xiong et al.
Summary: This study reveals the important role of m6A modification patterns in shaping the tumor microenvironment of glioblastoma. The developed GM-score can identify individual patients' m6A modification patterns, enabling personalized and effective anti-tumor immunotherapy strategies.
FRONTIERS IN IMMUNOLOGY
(2022)
Review
Neurosciences
Kristyn Galbraith et al.
Summary: DNA methylation plays a crucial role in tumor diagnosis, allowing for tumor classification, assessment of gene methylation status, and analysis of the tumor microenvironment.
ACTA NEUROPATHOLOGICA COMMUNICATIONS
(2022)
Article
Oncology
Vincenza Granata et al.
Summary: This study aimed to evaluate the predictive capacity of radiomic features extracted from computed tomography (CT) in predicting histopathological outcomes following liver resection in patients with colorectal liver metastases. The results showed that radiomics data can identify several prognostic features that may affect treatment choice, such as tumor growth pattern, tumor budding, mucinous type, and recurrence.
Article
Oncology
Yujia Chen et al.
Summary: This study revealed the critical role of m6A-related lncRNAs in glioma and elucidated that LNCTAM34A could promote glioma proliferation, migration, and epithelial-mesenchymal transition (EMT).
FRONTIERS IN ONCOLOGY
(2022)
Article
Cell Biology
Limin Yue et al.
Summary: This study constructed a risk score prediction model for gastric cancer patients based on age, gender, and m6A modification genes FTO and RBM15. The risk score was identified as an independent prognostic factor, and patients with high risk scores had poorer prognosis. The model's predictive value was verified using data from the GEO database.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2022)
Article
Public, Environmental & Occupational Health
Junaid Rashid et al.
Summary: This study proposes a novel method for predicting chronic diseases using artificial intelligence and neural networks, and demonstrates its superiority in terms of accuracy and processing time compared to other methods. It contributes to early diagnosis of chronic diseases and the development of online diagnosis systems.
FRONTIERS IN PUBLIC HEALTH
(2022)
Article
Immunology
Yongfei Fan et al.
Summary: The modification characteristics of RNA m(6)A in the tumor microenvironment of non-small cell lung cancer (NSCLC) were analyzed, providing insights for the development of more effective clinical immunotherapeutic strategies.
JOURNAL OF INFLAMMATION RESEARCH
(2022)
Review
Genetics & Heredity
Mengying Zhou et al.
Summary: Breast cancer, with its high molecular heterogeneity, is the leading cause of cancer deaths in women. N6-methyladenosine (m6A), the most common mRNA internal modification in eukaryotic cells, has reversible modification process regulated by writer, reader, and eraser enzymes. Abnormal m6A modifications in breast cancer can impact key signaling pathways and serve as markers, targets, or regulators for diagnosis, prognosis prediction, and treatment.
FRONTIERS IN GENETICS
(2022)
Review
Biochemistry & Molecular Biology
Chenxi Hu et al.
Summary: This review discusses the multifaceted roles of METTL3 in regulating specific molecular signaling pathways in different types of cancers and its impact on the tumor immune microenvironment. The potential for therapeutic targeting of METTL3 in cancer treatment is also discussed.
Review
Biochemistry & Molecular Biology
Wei Li et al.
Summary: This review summarizes the existing knowledge on N-6-methyladenosine (m(6)A) modifications involved in tumor immune escape (TIE), explores their potential mechanisms, and provides an overview of available drugs targeting m(6)A modifications.
Article
Pharmacology & Pharmacy
Hong Li et al.
Summary: ALKBH1 plays a crucial role in the development of lung cancer, with its overexpression promoting invasion and migration abilities of lung cancer cells, while its silencing suppresses these capabilities. Analyzing the biochemical characteristics and structure of the enzyme provides new insights for the design of cancer therapies based on ALKBH1.
BIOCHEMICAL PHARMACOLOGY
(2021)
Article
Oncology
Xin Wang et al.
Summary: The study found a significant increase in global mRNA m6A methylation levels in patients with laryngeal squamous cell carcinoma (LSCC), highlighting the essential roles of RBM15 and IGF2BP3 in m6A methylation modification. This study identified a novel RNA regulatory mechanism in LSCC.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
(2021)
Article
Immunology
Yi Jin et al.
Summary: The study highlights the significant role of m6A regulators in adrenocortical carcinoma (ACC), showing distinct m6A patterns associated with clinical outcomes and tumor immune microenvironment. By establishing a prognostic model and validating key modifications, the study reveals the potential importance of m6A modifications in ACC development and prognosis.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Oncology
Jacques Ferlay et al.
Summary: The study briefly reviews the methods and data sources used in compiling the IARC GLOBOCAN cancer statistics for 2020 and summarizes the main results. It estimated that there were nearly 19.3 million new cancer cases and almost 10 million cancer deaths worldwide in 2020, with the most commonly diagnosed cancers being female breast cancer and lung cancer, and the most common causes of cancer death being lung cancer and liver cancer.
INTERNATIONAL JOURNAL OF CANCER
(2021)
Article
Oncology
Zirui Zhao et al.
Summary: This study constructed a model with necroptosis-related lncRNAs to predict prognosis and aid in precision medication for gastric cancer patients. Analysis of IC50 differences between risk groups and clustering helped effectively distinguish between cold and hot tumors, contributing to precise mediation.
JOURNAL OF ONCOLOGY
(2021)
Letter
Oncology
Fengjie Jiang et al.
Summary: This study identified that HNRNPA2B1 is upregulated in multiple myeloma (MM) patients and negatively correlated with prognosis, playing a role in regulating cell proliferation by modulating AKT3 expression. This suggests that HNRNPA2B1 may act as a potential therapeutic target for MM through the ILF3-dependent pattern.
JOURNAL OF HEMATOLOGY & ONCOLOGY
(2021)
Article
Cell Biology
Shizhi Wang et al.
Summary: This study conducted a comprehensive pan-cancer analysis on FARGs, revealing their key roles in HPV-related cancers, especially in cervical cancer. By developing a prognostic risk score model and a nomogram model, accurate predictions were made for overall survival and recurrence-free survival in cervical cancer.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2021)
Review
Biochemistry & Molecular Biology
Stephanie Oerum et al.
Summary: Gene expression is regulated through various levels, including chemical modifications on RNA during or after transcription. One such modification is N6-methylation, which affects the structure, stability, degradation, and cellular interactions of the modified RNA, with dysregulation linked to multiple human cancers.RNA methyltransferases are the enzymes responsible for these modifications, and structural characterization of these enzymes is critical for understanding their functions.
NUCLEIC ACIDS RESEARCH
(2021)
Article
Cell Biology
Peilin Cong et al.
Summary: m6A RNA methylation regulators and their targets play crucial roles in the occurrence, progression, and prognosis of glioma. A seven-gene signature including METTL3, COL18A1, NASP, PHLPP2, TIMP1, U2AF2, and VEGFA was established and validated, showing a good capability for predicting glioma survival and guiding therapeutic customization and clinical decision-making. The study also identified genes influencing anticancer drug responses, contributing to early phase clinical trials of drug development.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2021)
Review
Biochemistry & Molecular Biology
Nicholas A. Wallace
TRENDS IN MICROBIOLOGY
(2020)
Article
Biochemistry & Molecular Biology
Bo Zhang et al.
Article
Medicine, Research & Experimental
Amit Gupta et al.
LABORATORY INVESTIGATION
(2020)
Article
Oncology
Jingxin Pan et al.
FRONTIERS IN ONCOLOGY
(2020)
Article
Oncology
Li-chong Wang et al.
FRONTIERS IN ONCOLOGY
(2020)
Review
Medicine, Research & Experimental
Ting Sun et al.
BIOMEDICINE & PHARMACOTHERAPY
(2019)
Article
Multidisciplinary Sciences
Seungwon Yang et al.
NATURE COMMUNICATIONS
(2019)
Article
Oncology
Feng-Cai Zhu et al.
Article
Biochemistry & Molecular Biology
Yunhao Chen et al.
Article
Biochemistry & Molecular Biology
Yi Zhang et al.
Review
Biotechnology & Applied Microbiology
Zhen-Xian Liu et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY
(2018)
